Biocodex-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Biocodex - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013924
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biocodex (Biocodex) is a drug manufacturing company that develops and commercializes drugs. The company offers products for gastro enteric diseases, pain management, neurological and psychiatric conditions, rheumatic pains, and ENT conditions. Its products include Saccharomyces boulardii, an antidiarrheal yeast based probiotic, cough syrup, vitamins, and calcium supplements. The company has partnership with universities and research organizations to advance its research. Biocodex offer its products through wholly owned subsidiaries and distributors in North America, South America, Europe, Asia Pacific and Africa. The company has subsidiaries in Mexico, Canada, Belgium, Russia, the US, Morocco, and Turkey. Biocodex is headquartered in Paris, France.

Biocodex – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biocodex, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biocodex, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biocodex, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biocodex, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Biocodex, Medical Devices Deals, 2011 to YTD 2017 9
Biocodex, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Biocodex, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Biocodex Acquires Rights To Totect, Anthracycline Extravasation Medicine, From Apricus Biosciences 11
Biocodex Acquires Non Opthalmic Arm Of Laboratoire Leurquin Mediolanum 12
Venture Financing 13
MaaT Pharma Raises USD11 Million in Series A Financing 13
Partnerships 14
Dr. Reddy’s Labs Enters into Distribution Agreement with Biocodex 14
Martin Dow Enters into Agreement with Biocodex 15
Licensing Agreements 16
Biocodex Enters into Licensing Agreement with Neurim Pharma 16
China Medical System Enters Into Licensing Agreement With Biocodex For Stimol 17
Sinclair IS Pharma Enters Into Agreement With Biocodex For Dermatology Portfolio 18
Asset Transactions 19
Clinigen Acquires Rights to Totect from Biocodex USA 19
Acquisition 20
Biocodex Acquires Algol Pharma from Algol 20
Biocodex – Key Competitors 21
Biocodex – Key Employees 22
Biocodex – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Biocodex, Pharmaceuticals & Healthcare, Key Facts 2
Biocodex, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biocodex, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biocodex, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biocodex, Deals By Therapy Area, 2011 to YTD 2017 8
Biocodex, Medical Devices Deals, 2011 to YTD 2017 9
Biocodex, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Biocodex Acquires Rights To Totect, Anthracycline Extravasation Medicine, From Apricus Biosciences 11
Biocodex Acquires Non Opthalmic Arm Of Laboratoire Leurquin Mediolanum 12
MaaT Pharma Raises USD11 Million in Series A Financing 13
Dr. Reddy’s Labs Enters into Distribution Agreement with Biocodex 14
Martin Dow Enters into Agreement with Biocodex 15
Biocodex Enters into Licensing Agreement with Neurim Pharma 16
China Medical System Enters Into Licensing Agreement With Biocodex For Stimol 17
Sinclair IS Pharma Enters Into Agreement With Biocodex For Dermatology Portfolio 18
Clinigen Acquires Rights to Totect from Biocodex USA 19
Biocodex Acquires Algol Pharma from Algol 20
Biocodex, Key Competitors 21
Biocodex, Key Employees 22
Biocodex, Subsidiaries 23

★海外企業調査レポート[Biocodex-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CAT Telecom Public Co Ltd:企業の戦略的SWOT分析
    CAT Telecom Public Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Cavion LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Cavion LLC (Cavion), formerly Tau Therapeutics LLC is a clinical stage pharmaceutical company that develops modulators and drugs. The company researches and develops T-type calcium channel (Cav3) inhibitors for the treatment of neurologic and oncologic diseases. It provides pipeline products …
  • Straumann Holding AG (STMN):企業の財務・戦略的SWOT分析
    Straumann Holding AG (STMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Akari Therapeutics Plc (AKTX):企業の財務・戦略的SWOT分析
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company. The company is engaged in the development of therapeutic treatments for rare and orphan autoimmune and inflammatory diseases. It offers coversin drugs that act on complement component-C5 that hel …
  • SARomics Biostructures AB:製薬・医療:M&Aディール及び事業提携情報
    Summary SARomics Biostructures AB (Saromics) is a contract research organization that offers structural biology and drug discovery outsourcing services platform for biotech and pharmaceutical companies. The organization provides services in protein crystallization, protein crystallography, protein N …
  • The Housing Bank for Trade and Finance:企業の戦略・SWOT・財務分析
    The Housing Bank for Trade and Finance - Strategy, SWOT and Corporate Finance Report Summary The Housing Bank for Trade and Finance - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Tricida Inc (TCDA):製薬・医療:M&Aディール及び事業提携情報
    Summary Tricida Inc (Tricida), formerly Trilypsa Inc is a clinical-stage pharmaceutical and drug discovery company. The company discovers and develops novel non-absorbed therapies for the treatment of renal, metabolic and cardiovascular diseases. Its lead drug candidate TRC101, is under clinical dev …
  • Saudi Arabian Oil Co (2222):企業の財務・戦略的SWOT分析
    Saudi Arabian Oil Co (2222) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sharjah Electricity & Water Authority:企業の戦略的SWOT分析
    Sharjah Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • T2 Biosystems Inc (TTOO):企業の製品パイプライン分析2018
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • EnWave Corp (ENW):企業の財務・戦略的SWOT分析
    EnWave Corp (ENW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Xbrane Biopharma AB (XBRANE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • YPF SA:企業のM&A・事業提携・投資動向
    YPF SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's YPF SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • Centrica Plc (CNA)-石油・ガス分野:企業M&A・提携分析
    Summary Centrica plc (Centrica) is an integrated energy company. It carries out electricity generation through and combined cycle gas turbine (CCGT) power stations, and nuclear power plants through its stake in EDF Energy Nuclear Generation. Centrica secures and supply gas and electricity to homes a …
  • Moximed Inc:医療機器:M&Aディール及び事業提携情報
    Summary Moximed Inc (Moximed), formerly ExploraMed NC4, Inc. focuses to develop unicompartmental load absorber implants for patients with painful knee osteoarthritis (OA). The company provides Atlas Knee System, an implantable knee joint unloader which works as a shock absorber for pre-arthroplasty …
  • Ultimovacs AS-製薬・医療分野:企業M&A・提携分析
    Summary Ultimovacs AS (Ultimovacs) is a provider of novel immunotherapies for cancer treatment. The company develops synthetic peptide based therapeutic vaccines that can be used on its own and also in combination with conventional therapies such as surgery, chemotherapy, and irradiation. Its UV1 is …
  • Host Hotels & Resorts, Inc.:企業の戦略・SWOT・財務情報
    Host Hotels & Resorts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Host Hotels & Resorts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kraton Corp (KRA):企業の財務・戦略的SWOT分析
    Summary Kraton Corp (Kraton) is a chemical company that develops, manufactures and markets biobased chemicals and specialty polymers. The company offers products such as adhesives and sealants, coatings, paving and roofing chemicals, compounding solutions, oil gels, automotive chemicals, fuel additi …
  • Petrogrand AB:石油・ガス:M&Aディール及び事業提携情報
    Summary Petrogrand AB (Petrogrand), formerly Malka Oil AB is an oil and gas company that acquires, explores and produces crude oil and natural gas assets. The company carries out management and refining of Russian oil assets. It holds interests in the Nizhne-Paninsky license area located in northwes …
  • Seven Generations Energy Ltd (VII):企業の財務・戦略的SWOT分析
    Seven Generations Energy Ltd (VII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆